Quick Answer
VERACYTE, INC. reported R&D Expense of $70.81 million for fiscal year 2025.
VERACYTE, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $70.81M | +2.2% |
| 2024 | $69.29M | +20.9% |
| 2023 | $57.30M | +41.1% |
| 2022 | $40.60M | +36.1% |
| 2021 | $29.84M | +73.5% |
| 2020 | $17.20M | +15.8% |
| 2019 | $14.85M | +0.2% |
| 2018 | $14.82M | +6.8% |
| 2017 | $13.88M | -9.4% |
| 2016 | $15.32M | +19.8% |
| 2015 | $12.80M | +30.5% |
| 2014 | $9.80M | +25.5% |
| 2013 | $7.81M | +18.2% |
| 2012 | $6.61M | -1.1% |
| 2011 | $6.68M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $15.98M | -9.1% | -1.7% |
| June 30, 2025 | $16.26M | -1.2% | -8.2% |
| March 31, 2025 | $17.72M | +11.0% | +0.8% |
| September 30, 2024 | $17.57M | +31.9% | +6.7% |
| June 30, 2024 | $16.46M | +31.3% | +3.1% |
| March 31, 2024 | $15.96M | +25.0% | +19.8% |
| September 30, 2023 | $13.32M | +23.7% | +6.2% |
| June 30, 2023 | $12.54M | +33.7% | -1.8% |
- VERACYTE, INC. showed an increase of +2.2% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2025 period, VERACYTE, INC.’s r&d expense has grown by 960.1% (from $6.68 million to $70.81 million).
- The most recent figure is from VERACYTE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: